Letter: Predictors of the Therapeutic Efficacy and Consideration of the Best Combination Therapy of Sodium-Glucose Co-transporter 2 Inhibitors (Diabetes Metab J 2019;43:158-73)

Diabetes Metab J. 2019 Jun;43(3):377-378. doi: 10.4093/dmj.2018.0091.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Canagliflozin
  • Glucose
  • Sodium
  • Sodium-Glucose Transporter 2 Inhibitors*
  • Symporters*

Substances

  • Sodium-Glucose Transporter 2 Inhibitors
  • Symporters
  • Canagliflozin
  • Sodium
  • Glucose